NIH - Innovation for HIV Vaccine Discovery

The purpose of this Funding Opportunity Announcement (FOA) is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV.  In keeping with the high risk, high impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects.  Continued funding for the full award duration is dependent upon achieving negotiated “Go/No-Go” criteria by the end of Year 2.  


Agency Name: 
National Institutes of Health
Contact Name: 
Penny D'Agnone
Grant Amount: 
$350,000 per year in direct costs. Applicants may request up to an additional $150,000 when justified in using non-human models
Grant Location: 
External Deadline: 
Saturday, July 1, 2017
Grant Type: 
Grant Area: 
Grant Eligibility: